NEWBRY logo

Newbury Pharmaceuticals AB (publ) Stock Price

OM:NEWBRY Community·SEK 44.7m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 1 Fair Values set on narratives written by author

NEWBRY Share Price Performance

SEK 1.47
-2.05 (-58.24%)
SEK 1.47
-2.05 (-58.24%)
Price SEK 1.47

NEWBRY Community Narratives

There are no narratives available yet.

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Moderate risk with adequate balance sheet.

5 Risks
0 Rewards

Newbury Pharmaceuticals AB (publ) Key Details

SEK 31.6m

Revenue

SEK 18.7m

Cost of Revenue

SEK 12.8m

Gross Profit

SEK 36.7m

Other Expenses

-SEK 23.9m

Earnings

Last Reported Earnings
Aug 31, 2025
Next Reporting Earnings
Dec 10, 2025
-0.79
40.63%
-75.65%
0%
View Full Analysis

About NEWBRY

Founded
2020
Employees
7
CEO
Karl Alexius Tiger Karlsson
WebsiteView website
www.newburypharma.com

Newbury Pharmaceuticals AB (publ) operates as hybrid pharmaceutical company in Sweden and the Scandinavian market. The company offers oncology, rare diseases, neurology, and other treatment products. Newbury Pharmaceuticals AB (publ) was incorporated in 2020 and is based in Lund, Sweden.

Recent NEWBRY News & Updates

Recent updates

No updates